Enteric fever, commonly known as typhoid fever, remains a significant public health concern globally, particularly in developing nations. It is caused by the Salmonella enterica serotype Typhi and Paratyphi bacteria. The primary challenge in managing this disease lies in its non-specific clinical presentation, antimicrobial resistance, and the lack of effective vaccines. This article aims to outline comprehensive strategies for the effective management of enteric fever in clinical practice.
Timely diagnosis is crucial for effective management. Clinicians should maintain a high index of suspicion, particularly in patients with fever and recent travel history to endemic regions. Blood culture remains the gold standard for diagnosis, although newer molecular diagnostic tools are demonstrating promise.
Empirical antibiotic therapy should be initiated promptly, taking into account local antimicrobial resistance patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. However, increasing resistance to these drugs necessitates regular surveillance and modification of treatment guidelines.
Vaccination is an essential component of enteric fever management. While current vaccines are not entirely efficacious, they still offer substantial protection. Vaccination should be considered for individuals traveling to endemic regions and in outbreak situations.
Public health measures, including safe water supply, sanitation, and food safety, are crucial in preventing enteric fever. Health education on personal hygiene practices can also significantly reduce the incidence of this disease.
Effective management of enteric fever requires a multi-faceted approach, encompassing early diagnosis, appropriate antimicrobial therapy, vaccination, and public health measures. Clinicians should stay updated on local epidemiology and resistance patterns to guide their management strategies. Further research into more effective vaccines and diagnostic tools is necessary to combat this persistent public health challenge.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation